Effect of the Glucagon-Like Peptide-1 Analogue Liraglutide on Coronary Microvascular Function in Patients With Type 2 Diabetes – A Randomized, Single-Blinded, Cross-Over Pilot Study

Cardiovascular Diabetology - United Kingdom
doi 10.1186/s12933-015-0206-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Glucagon-Like Peptide Analogues for Type 2 Diabetes Mellitus

2007English

Glucagon-Like Peptide 1 Receptor Agonists: A New Approach to Type 2 Diabetes Management

South African Family Practice
2013English

The Glucagon-Like Peptide-1 Analog Liraglutide Suppresses Ghrelin and Controls Diabetes in a Patient With Prader-Willi Syndrome

Endocrine Journal
EndocrinologyMetabolismDiabetes
2012English

Effect of Glucagon-Like Peptide 1(7-36) Amide on Glucose Effectiveness and Insulin Action in People With Type 2 Diabetes

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2000English

Improved Glycemic Control With No Weight Increase in Patients With Type 2 Diabetes After Once-Daily Treatment With the Long-Acting Glucagon-Like Peptide 1 Analog Liraglutide (NN2211): A 12-Week, Double-Blind, Randomized, Controlled Trial

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2004English

Beneficial Effects of a Paleolithic Diet on Cardiovascular Risk Factors in Type 2 Diabetes: A Randomized Cross-Over Pilot Study

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2009English

The Association of the Treatment With Glucagon-Like Peptide-1 Receptor Agonist Exenatide or Insulin With Cardiovascular Outcomes in Patients With Type 2 Diabetes: A Retrospective Observational Study

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2015English

Sex Differences in Coronary Microvascular Function in Individuals With Type 2 Diabetes Mellitus

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Impaired Cardiometabolic Responses to Glucagon-Like Peptide 1 in Obesity and Type 2 Diabetes Mellitus

Basic Research in Cardiology
Cardiovascular MedicinePhysiologyCardiology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy